2022年欧洲临床营养与代谢学会和欧洲肥胖研究学会《肌肉减少性肥胖的定义和诊断标准共识》解读及启示

Interpretation and Clinical Significance of the Definition and Diagnostic Criteria for Sarcopenic Obesity:ESPEN and EASO Consensus Statement

近年来,欧洲临床营养与代谢学会(ESPEN)和欧洲肥胖研究学会(EASO)的专家组成员对肌肉减少性肥胖(SO)的相关研究进行了系统地评价。2022年2月,ESPEN和EASO共同发布了《肌肉减少性肥胖的定义和诊断标准共识》,该共识对SO的定义和诊断进行了详细的阐述,旨在就SO的定义和诊断达成共识,为研究人员和临床工作者提供参考依据,以推进SO预防和治疗的发展。本文主要对《肌肉减少性肥胖的定义和诊断标准共识》中SO的定义,诊断流程包括筛查、诊断和分期标准,拟采用的方法和相关的参数等主要内容进行梳理和解读,旨在为国内医务工作者提供更多参考。

In recent years,panelists from the European Society for Clinical Nutrition and Metabolism(ESPEN)and the European Association for the Study of Obesity(EASO)have conducted a systematic review of studies about sarcopenic obesity(SO).Then in February 2022,ESPEN and EASO jointly released the Definition and Diagnostic Criteria for Sarcopenic Obesity,in which the definition and diagnosis of SO were detailed,aiming to reach expert consensus on a definition and diagnostic criteria for SO,thereby providing a reference for researchers and clinicians to facilitate the development of prevention and treatment of SO.We primarily interpreted the definition and diagnostic procedure(including screening,diagnosis and staging with proposed implementation method and relevant parameters)for SO in the Definition and Diagnostic Criteria for Sarcopenic Obesity,providing Chinese medical workers with guidance for coping with SO.